In this Section |
255089 Prescription opioid abuse and comorbidity among participants in publically funded substance abuse treatment programs in Los Angeles CountyMonday, October 29, 2012
Prescription opioid abuse is becoming a serious public health problem in the United States. An estimated 80% of the global opioid supply has been consumed by Americans, representing only 4.6% of the world's population. The milligram per person use of prescription opioids in the U.S. increased by 402 % from 1997 to 2007 and unintentional overdose deaths involving opioid analgesics have exceeded the sum of deaths involving heroin or cocaine.
This study examined the impact of age, gender, race, and other prior experiences as well as physical and mental comorbid conditions among prescription opioid abouse population in publically funded susbstance abuse treatment programs in Los Angeles County. Data collected via the Los Angeles County Participant Reporting System (LACPRS) were analyzed. There were 4,912 opioid-related admission episodes to treatment facilities in Los Angeles County between 2005 and 2010. Whites, males, and older participants (45+) were significantly more likely to abuse prescription opioid (p<.0001). Participants with prescription opioid problems had significantly higher number of prior treatment episodes (p<.01) and were significantly more likely to have mental and physical health problems (e.g., emergency room visits, days in hospital) than participants with illicit drug problems (p<.0001). Our results suggest that it is imperative to move beyond “one-size-fits-all” approach to prevention and treatment of prescription opioid abuse that ignores the impact of age, gender, race, and comorbid psychiatric and physical conditions.
Learning Areas:
Chronic disease management and preventionPlanning of health education strategies, interventions, and programs Public health or related education Public health or related research Learning Objectives: Keywords: Drug Abuse Treatment, Drug Abuse Treatment
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I have been the principal and co-principal of multiple research projects on the impact of pharmaceutical drug abuse, racial and ethnic disparities in substance abuse treatment completion, medical marijuana users and community indicators, and meta-analysis on co-occurring mental and substance use disorders. Currently I am the principal investigator in examining the factors that are responsible for the effective prevention and treatment of prescription opioid abuse involving the impact of demographics and comorbid conditions. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 3384.0: Addressing Prescription Drug Use & Abuse
|